Preventing cognitive issues in Down syndrome models by targeting specific brain channels
Preventing cognitive impairment in mouse genetic models of Down syndrome by early postnatal suppression of Kir3.2 channel signaling
This study is looking at how blocking a specific brain channel early on might help prevent learning and memory problems in mice with Down syndrome, with hopes that it could lead to new treatments for people with the condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-10906674 on NIH RePORTER |
What this research studies
This research investigates how early suppression of Kir3.2 channel signaling can prevent cognitive impairment in mouse models of Down syndrome. By focusing on the genetic mechanisms that affect brain development, the study aims to understand how these channels influence the formation of neural circuits during critical early postnatal periods. The researchers will explore the effects of manipulating the Kcnj6 gene, which encodes the Kir3.2 channels, to see if this can restore normal brain function and improve cognitive outcomes. This approach could lead to new therapeutic strategies for individuals with Down syndrome.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with Down syndrome, particularly those who are in early developmental stages.
Not a fit: Patients who are older or have advanced cognitive impairments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that improve cognitive function in individuals with Down syndrome.
How similar studies have performed: While the specific approach of targeting Kir3.2 channels in Down syndrome models is novel, similar genetic interventions have shown promise in other cognitive impairment studies.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Kleschevnikov, Alexander M — University of California, San Diego
- Study coordinator: Kleschevnikov, Alexander M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.